Idexx Laboratories Stock Performance

IDXX Stock  USD 539.57  8.97  1.69%   
The company retains a Market Volatility (i.e., Beta) of 1.01, which attests to a somewhat significant risk relative to the market. IDEXX Laboratories returns are very sensitive to returns on the market. As the market goes up or down, IDEXX Laboratories is expected to follow. IDEXX Laboratories has an expected return of -0.0315%. Please make sure to check out IDEXX Laboratories maximum drawdown, as well as the relationship between the daily balance of power and relative strength index , to decide if IDEXX Laboratories performance from the past will be repeated in the future.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, IDEXX Laboratories is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more

Actual Historical Performance (%)

One Day Return
1.69
Five Day Return
1.25
Year To Date Return
(1.48)
Ten Year Return
787.52
All Time Return
57 K
Last Split Factor
2:1
Last Split Date
2015-06-16
1
IDEXX Laboratories Updates FY24 Earnings Guidance
02/05/2024
2
Disposition of 483 shares by Jonathan Mazelsky of IDEXX Laboratories at 206.94 subject to Rule 16b-3
02/21/2024
3
IDEXX Laboratories Rebounded After Significant Drawdown From July Highs
02/22/2024
4
Disposition of 1404 shares by Sophie Vandebroek of IDEXX Laboratories at 245.79 subject to Rule 16b-3
03/05/2024
5
Idexx Down 1.5 percent Since Last Earnings Report Can It Rebound
03/06/2024
6
Disposition of 680 shares by James Polewaczyk of IDEXX Laboratories at 559.3318 subject to Rule 16b-3
03/07/2024
7
Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc
03/08/2024
8
100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today
03/11/2024
9
IDEXX Laboratories, Inc. Stock Has Shown Weakness Lately But Financials Look Strong Should Prospective Shareholders Make The Leap
03/12/2024
10
IDEXX Laboratories earnings growth rate lags the 19 percent CAGR delivered to shareholders
03/19/2024
11
Heres How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years
03/27/2024
Begin Period Cash Flow112.5 M
  

IDEXX Laboratories Relative Risk vs. Return Landscape

If you would invest  55,505  in IDEXX Laboratories on December 29, 2023 and sell it today you would lose (1,548) from holding IDEXX Laboratories or give up 2.79% of portfolio value over 90 days. IDEXX Laboratories is currently does not generate positive expected returns and assumes 1.7547% risk (volatility on return distribution) over the 90 days horizon. In different words, 15% of stocks are less volatile than IDEXX, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days IDEXX Laboratories is expected to under-perform the market. In addition to that, the company is 3.06 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.23 per unit of volatility.

IDEXX Laboratories Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for IDEXX Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IDEXX Laboratories, and traders can use it to determine the average amount a IDEXX Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0179

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIDXX

Estimated Market Risk

 1.75
  actual daily
15
85% of assets are more volatile

Expected Return

 -0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average IDEXX Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IDEXX Laboratories by adding IDEXX Laboratories to a well-diversified portfolio.

IDEXX Laboratories Fundamentals Growth

IDEXX Stock prices reflect investors' perceptions of the future prospects and financial health of IDEXX Laboratories, and IDEXX Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IDEXX Stock performance.

About IDEXX Laboratories Performance

To evaluate IDEXX Laboratories Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when IDEXX Laboratories generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare IDEXX Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand IDEXX Laboratories market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents IDEXX's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Return On Capital Employed 0.48  0.26 
Return On Assets 0.26  0.27 
Return On Equity 0.57  0.60 

Things to note about IDEXX Laboratories performance evaluation

Checking the ongoing alerts about IDEXX Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IDEXX Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
IDEXX Laboratories generated a negative expected return over the last 90 days
IDEXX Laboratories is unlikely to experience financial distress in the next 2 years
The company currently holds 947.88 M in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist IDEXX Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, IDEXX Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IDEXX Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IDEXX to invest in growth at high rates of return. When we think about IDEXX Laboratories' use of debt, we should always consider it together with cash and equity.
IDEXX Laboratories has a strong financial position based on the latest SEC filings
Over 93.0% of IDEXX Laboratories shares are owned by institutional investors
Latest headline from benzinga.com: Heres How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years
Evaluating IDEXX Laboratories' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate IDEXX Laboratories' stock performance include:
  • Analyzing IDEXX Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IDEXX Laboratories' stock is overvalued or undervalued compared to its peers.
  • Examining IDEXX Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating IDEXX Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IDEXX Laboratories' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of IDEXX Laboratories' stock. These opinions can provide insight into IDEXX Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating IDEXX Laboratories' stock performance is not an exact science, and many factors can impact IDEXX Laboratories' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.121
Earnings Share
10.09
Revenue Per Share
44.073
Quarterly Revenue Growth
0.088
Return On Assets
0.2283
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.